Variant report

Variant	esv15484
Chromosome Location	chr19:41626703-41628623
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:24)
CpG islands
(count:61)
Chromatin interactive
region (count:1)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:24 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CTCF	chr19:41628056-41628084	H1-hESC	embryonic stem cell:	n/a	n/a
2	HEY1	chr19:41627636-41627840	K562	blood:	n/a	n/a
3	MAX	chr19:41627062-41627463	K562	blood:	n/a	chr19:41627257-41627266
4	MYC	chr19:41627234-41627283	K562	blood:	n/a	chr19:41627257-41627266
5	NR3C1	chr19:41626999-41627610	A549	lung:	n/a	chr19:41627542-41627555
6	NR3C1	chr19:41626954-41627570	A549	lung:	n/a	chr19:41627542-41627555
7	PBX3	chr19:41627123-41627243	GM12878	blood:	n/a	chr19:41627125-41627145
8	POLR2A	chr19:41627822-41627860	K562	blood:	n/a	n/a
9	POLR2A	chr19:41626865-41627013	K562	blood:	n/a	n/a
10	POLR2A	chr19:41627393-41627582	K562	blood:	n/a	n/a
11	POLR2A	chr19:41627600-41627610	K562	blood:	n/a	n/a
12	POLR2A	chr19:41626921-41627067	MCF-7	breast:	n/a	n/a
13	POLR2A	chr19:41627632-41627648	K562	blood:	n/a	n/a
14	POLR2A	chr19:41626963-41627085	GM12878	blood:	n/a	n/a
15	POLR2A	chr19:41627072-41627076	MCF-7	breast:	n/a	n/a
16	POLR2A	chr19:41626874-41626925	HepG2	liver:	n/a	n/a
17	POLR2A	chr19:41627675-41627810	K562	blood:	n/a	n/a
18	POLR2A	chr19:41627077-41627082	MCF-7	breast:	n/a	n/a
19	POLR2A	chr19:41627139-41627339	K562	blood:	n/a	n/a
20	POLR2A	chr19:41626936-41627155	MCF-7	breast:	n/a	n/a
21	POLR2A	chr19:41627157-41627273	MCF-7	breast:	n/a	n/a
22	POLR2A	chr19:41627108-41627323	MCF-7	breast:	n/a	n/a
23	POLR2A	chr19:41627027-41627028	K562	blood:	n/a	n/a
24	RUNX3	chr19:41627016-41627271	GM12878	blood:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:41627236-41627286	NHDF-neo	bronchial:	n/a
2	chr19:41627236-41627286	HEEpiC	esophagus:	n/a
3	chr19:41627236-41627286	GM12892	blood:	n/a
4	chr19:41627236-41627286	SK-N-MC	brain:	n/a
5	chr19:41627236-41627286	ECC-1	luminal epithelium:	n/a
6	chr19:41627236-41627286	Hela-S3	cervix:	n/a
7	chr19:41627236-41627286	A549	lung:	n/a
8	chr19:41627236-41627286	GM19239	blood:	n/a
9	chr19:41627236-41627286	AoSMC	blood vessel:	n/a
10	chr19:41627236-41627286	IMR90	lung:	fetal
11	chr19:41627236-41627286	SK-N-SH	brain:	n/a
12	chr19:41627236-41627286	H1-hESC	embryonic stem cell:	embryo
13	chr19:41627236-41627286	LNCaP	prostate:	n/a
14	chr19:41627236-41627286	HRPEpiC	eye:	n/a
15	chr19:41627236-41627286	HCF	heart:	n/a
16	chr19:41627236-41627286	HL-60	blood:	n/a
17	chr19:41627236-41627286	AG09309	skin:	n/a
18	chr19:41627236-41627286	Hepatocyte	liver:	n/a
19	chr19:41627236-41627286	GM12878	blood:	n/a
20	chr19:41627236-41627286	CMK	blood:	n/a
21	chr19:41627236-41627286	AG09319	gingival:	n/a
22	chr19:41627236-41627286	ProgFib	skin:	n/a
23	chr19:41627236-41627286	HMEC	breast:	n/a
24	chr19:41627236-41627286	RPTEC	kidney:	n/a
25	chr19:41627236-41627286	U87	brain:	n/a
26	chr19:41627236-41627286	HCPEpiC	choroid plexus:	n/a
27	chr19:41627236-41627286	PrEC	prostate:	n/a
28	chr19:41627236-41627286	HNPCEpiC	eye:	n/a
29	chr19:41627236-41627286	Jurkat	blood:	n/a
30	chr19:41627236-41627286	HCM	heart:	n/a
31	chr19:41627236-41627286	HRCEpiC	kidney:	n/a
32	chr19:41627236-41627286	AG10803	skin:	n/a
33	chr19:41627236-41627286	T-47D	breast:	n/a
34	chr19:41627236-41627286	SK-N-SH_RA	brain:	n/a
35	chr19:41627236-41627286	NHBE	bronchial:	n/a
36	chr19:41627236-41627286	HepG2	liver:	n/a
37	chr19:41627236-41627286	PFSK-1	brain:	n/a
38	chr19:41627236-41627286	GM06990	blood:	n/a
39	chr19:41627236-41627286	HEK293	kidney:	embryo
40	chr19:41627236-41627286	Caco-2	colon:	n/a
41	chr19:41627236-41627286	AG04450	lung:	fetal
42	chr19:41627236-41627286	HCT-116	colon:	n/a
43	chr19:41627236-41627286	HRE	kidney:	n/a
44	chr19:41627236-41627286	AG04449	skin:	fetal
45	chr19:41627236-41627286	PANC-1	pancreas:	n/a
46	chr19:41627236-41627286	HPAEpiC	pulmonary alveolar:	n/a
47	chr19:41627236-41627286	NH-A	brain:	n/a
48	chr19:41627236-41627286	HAEpiC	amniotic membrane:	n/a
49	chr19:41627236-41627286	ovcar-3	ovarian:	n/a
50	chr19:41627236-41627286	NT2-D1	testis:	n/a

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr19:41621979..41624352-chr19:41625905..41628342,2	K562	blood:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CYP2A7P1-2	chr19:41626672-41627570	NONHSAT066433

No data

Variant related genes	Relation type
CYP2F1	TF binding region
CYP2F1	CpG island

Extended variants
information (count: 122 )
Associated
traits (count: 62 )

Variant overlapped rSNPs/rCNVs (count:122 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs111358090	chr19:41626731-41626732	Weak transcription Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
2	rs76562049	chr19:41626743-41626744	Weak transcription Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
3	rs76241598	chr19:41626744-41626745	Weak transcription Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
4	rs374756024	chr19:41626765-41626766	Weak transcription Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
5	rs148643348	chr19:41626766-41626767	Weak transcription Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
6	rs528370692	chr19:41626812-41626813	Weak transcription Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
7	rs117659286	chr19:41626908-41626909	Weak transcription Enhancers Flanking Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
8	rs568275339	chr19:41626913-41626914	Weak transcription Enhancers Flanking Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
9	rs114028315	chr19:41626919-41626920	Weak transcription Enhancers Flanking Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
10	rs73545055	chr19:41626923-41626924	Weak transcription Enhancers Flanking Active TSS	TF binding region lncRNA	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs568942048	chr19:41626929-41626930	Weak transcription Enhancers Flanking Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
12	rs373412399	chr19:41626970-41626971	Weak transcription Enhancers Flanking Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
13	rs559173586	chr19:41626983-41626984	Weak transcription Enhancers Flanking Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
14	rs546794972	chr19:41627041-41627042	Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS ZNF genes & repeats Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
15	rs571073556	chr19:41627082-41627083	Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS ZNF genes & repeats Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
16	rs534999016	chr19:41627088-41627089	Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS ZNF genes & repeats Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
17	rs553582799	chr19:41627092-41627093	Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS ZNF genes & repeats Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
18	rs116692516	chr19:41627106-41627107	Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS ZNF genes & repeats Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
19	rs151151658	chr19:41627110-41627111	Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS ZNF genes & repeats Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
20	rs556968279	chr19:41627131-41627132	Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS ZNF genes & repeats Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
21	rs575309953	chr19:41627137-41627138	Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS ZNF genes & repeats Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
22	rs545938410	chr19:41627147-41627148	Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS ZNF genes & repeats Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
23	rs34159490	chr19:41627154-41627155	Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS ZNF genes & repeats Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
24	rs370738856	chr19:41627157-41627158	Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS ZNF genes & repeats Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
25	rs113399285	chr19:41627159-41627160	Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS ZNF genes & repeats Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
26	rs112669251	chr19:41627174-41627175	Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS ZNF genes & repeats Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
27	rs540058724	chr19:41627198-41627199	Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS ZNF genes & repeats Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
28	rs113031476	chr19:41627207-41627208	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
29	rs113512828	chr19:41627233-41627234	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
30	rs550580377	chr19:41627236-41627237	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
31	rs562496201	chr19:41627263-41627264	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
32	rs533058680	chr19:41627271-41627272	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
33	rs551542843	chr19:41627275-41627276	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
34	rs183947879	chr19:41627277-41627278	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
35	rs73931411	chr19:41627283-41627284	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
36	rs143953786	chr19:41627285-41627286	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island lncRNA	1 gene(s)	Overlapped CNVs	n/a
37	rs188279309	chr19:41627330-41627331	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
38	rs73545057	chr19:41627340-41627341	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
39	rs112284487	chr19:41627346-41627347	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
40	rs386809333	chr19:41627349-41627350	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
41	rs556931482	chr19:41627382-41627383	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
42	rs140625276	chr19:41627396-41627397	Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
43	rs2287941	chr19:41627401-41627402	Weak transcription Enhancers Active TSS	TF binding region lncRNA	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs2287942	chr19:41627402-41627403	Weak transcription Enhancers Active TSS	TF binding region lncRNA	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs140643766	chr19:41627408-41627409	Weak transcription Enhancers Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
46	rs200553377	chr19:41627438-41627439	Weak transcription Enhancers Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
47	rs540391559	chr19:41627449-41627450	Weak transcription Enhancers Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
48	rs149137622	chr19:41627453-41627454	Weak transcription Enhancers Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
49	rs561770969	chr19:41627457-41627458	Weak transcription Enhancers Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
50	rs143213883	chr19:41627486-41627487	Weak transcription Enhancers Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:62)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Ovarian neoplasms	16753589	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	19029149	CNVD
Breast cancer	20409316	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Genital abnormality	22378287	CNVD
Hypospadia	22378287	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Astrocytoma	22246337	CNVD
early-passage human iPS cells	21368824	CNVD

Chromatin state (count:64 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:41620600-41627800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
2	chr19:41622600-41627000	Weak transcription	Pancreas	Pancrea
3	chr19:41624800-41628000	Enhancers	Primary T helper naive cells from peripheral blood	blood
4	chr19:41625600-41629200	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
5	chr19:41625800-41627000	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
6	chr19:41625800-41627400	Enhancers	Primary T helper naive cells fromperipheralblood	blood
7	chr19:41625800-41627400	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
8	chr19:41625800-41627600	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
9	chr19:41625800-41627600	Enhancers	Primary T helper cells fromperipheralblood	blood
10	chr19:41626000-41627000	Enhancers	Primary T helper cells PMA-I stimulated	--
11	chr19:41626000-41627400	Enhancers	Primary T cells from cord blood	blood
12	chr19:41626000-41627400	Enhancers	Primary T killer naive cells fromperipheralblood	blood
13	chr19:41626000-41627400	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
14	chr19:41626200-41626800	Flanking Active TSS	Primary T killer memory cells from peripheral blood	blood
15	chr19:41626200-41627600	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
16	chr19:41626400-41627200	Flanking Active TSS	Primary T cells fromperipheralblood	blood
17	chr19:41626400-41627600	Enhancers	Primary hematopoietic stem cells short term culture	blood
18	chr19:41626400-41627600	Enhancers	Primary T regulatory cells fromperipheralblood	blood
19	chr19:41626600-41627000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
20	chr19:41626600-41627600	Enhancers	Primary B cells from peripheral blood	blood
21	chr19:41626800-41627600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
22	chr19:41626800-41628000	Enhancers	Primary T killer memory cells from peripheral blood	blood
23	chr19:41627000-41627200	Flanking Bivalent TSS/Enh	H1 Derived Mesenchymal Stem Cells	ES cell derived
24	chr19:41627000-41627200	Flanking Active TSS	Primary T cells effector/memory enriched fromperipheralblood	blood
25	chr19:41627000-41627200	Enhancers	Esophagus	oesophagus
26	chr19:41627000-41627200	ZNF genes & repeats	Pancreas	Pancrea
27	chr19:41627000-41627400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
28	chr19:41627000-41627400	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
29	chr19:41627000-41627400	Enhancers	Primary monocytes fromperipheralblood	blood
30	chr19:41627000-41627400	Flanking Active TSS	Primary T helper cells PMA-I stimulated	--
31	chr19:41627000-41627400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
32	chr19:41627000-41627400	Enhancers	Duodenum Mucosa	Duodenum
33	chr19:41627000-41627400	Active TSS	Rectal Mucosa Donor 29	rectum
34	chr19:41627000-41627400	Flanking Active TSS	K562	blood
35	chr19:41627000-41627600	Enhancers	Monocytes-CD14+_RO01746	blood
36	chr19:41627200-41627400	Active TSS	Primary T cells effector/memory enriched fromperipheralblood	blood
37	chr19:41627200-41628800	Enhancers	Primary T cells fromperipheralblood	blood
38	chr19:41627200-41630400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
39	chr19:41627200-41633800	Weak transcription	Esophagus	oesophagus
40	chr19:41627200-41634000	Weak transcription	Pancreas	Pancrea
41	chr19:41627400-41627600	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
42	chr19:41627400-41627600	Active TSS	K562	blood
43	chr19:41627400-41628000	Enhancers	Primary T helper cells PMA-I stimulated	--
44	chr19:41627400-41628000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
45	chr19:41627400-41628200	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
46	chr19:41627400-41632800	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
47	chr19:41627400-41632800	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
48	chr19:41627400-41641600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
49	chr19:41627600-41629800	Weak transcription	Primary hematopoietic stem cells short term culture	blood
50	chr19:41627600-41632800	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links